JP2015127308A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015127308A5 JP2015127308A5 JP2013273140A JP2013273140A JP2015127308A5 JP 2015127308 A5 JP2015127308 A5 JP 2015127308A5 JP 2013273140 A JP2013273140 A JP 2013273140A JP 2013273140 A JP2013273140 A JP 2013273140A JP 2015127308 A5 JP2015127308 A5 JP 2015127308A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- combination
- prok1
- agent
- vegf antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 1
- 239000002257 antimetastatic agent Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 229960005395 cetuximab Drugs 0.000 claims 1
- -1 cetuximab Chemical compound 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229960002949 fluorouracil Drugs 0.000 claims 1
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 claims 1
- 229960004768 irinotecan Drugs 0.000 claims 1
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical group O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 claims 1
- 229960001756 oxaliplatin Drugs 0.000 claims 1
- 229960001972 panitumumab Drugs 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013273140A JP6320040B2 (ja) | 2013-12-27 | 2013-12-27 | 抗ｐｒｏｋ１抗体及び抗ｖｅｇｆ抗体併用による大腸癌の治療 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013273140A JP6320040B2 (ja) | 2013-12-27 | 2013-12-27 | 抗ｐｒｏｋ１抗体及び抗ｖｅｇｆ抗体併用による大腸癌の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015127308A JP2015127308A (ja) | 2015-07-09 |
| JP2015127308A5 true JP2015127308A5 (enExample) | 2017-02-09 |
| JP6320040B2 JP6320040B2 (ja) | 2018-05-09 |
Family
ID=53837492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013273140A Active JP6320040B2 (ja) | 2013-12-27 | 2013-12-27 | 抗ｐｒｏｋ１抗体及び抗ｖｅｇｆ抗体併用による大腸癌の治療 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6320040B2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230139178A1 (en) * | 2020-03-12 | 2023-05-04 | Toray Industries, Inc. | Medicament for treatment and/or prevention of cancer |
| JP2022122736A (ja) * | 2021-02-10 | 2022-08-23 | 国立大学法人福井大学 | 抗ｐｒｏｋ１抗体の利用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020172678A1 (en) * | 2000-06-23 | 2002-11-21 | Napoleone Ferrara | EG-VEGF nucleic acids and polypeptides and methods of use |
| JP2003292455A (ja) * | 2002-02-04 | 2003-10-15 | Takeda Chem Ind Ltd | 血管新生阻害剤 |
-
2013
- 2013-12-27 JP JP2013273140A patent/JP6320040B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122840T1 (el) | Ανθρωποποιημενα ή χιμαιρικα αντισωματα cd3 | |
| IL235261B (en) | Antibodies against claudin 18.2 useful in cancer diagnosis | |
| DK3909966T3 (da) | 19-nor c3,3-disubstitueret c21-n-pyrazolylsteroid til brug i behandling | |
| IL256687B (en) | Isolated tau-binding antibody and use thereof in therapy and diagnosis | |
| IL247221B (en) | Antibodies binding dengue virus, compositions comprising same and uses thereof | |
| IL243752B (en) | Multispecific antibodies, compositions comprising same and uses thereof | |
| LT2970456T (lt) | Būdai ir kompozicijos, skirti mrnr koduojamų antikūnų pristatymui | |
| CL2015001924A1 (es) | Anticuerpos anti-pdgfr-beta y usos relacionados. | |
| MX374785B (es) | Anticuerpos anti-fgfr2iiib afucosilados. | |
| HK1220405A1 (zh) | 治疗膀胱癌的方法 | |
| PH12014501164A1 (en) | Anti-cd98 antibodies and methods of use thereof | |
| HUE052223T2 (hu) | IGF-1R ellenanyag és alkalmazása rák kezelésében célzóeszközként | |
| EP3091030A4 (en) | Anti-human rankl antibody, humanized antibody, pharmaceutical compositions and uses thereof | |
| IL257274B (en) | Compositions and methods for treating cancers associated with etbr activation | |
| SI3265123T1 (sl) | Protitelesa, uporabe in postopki | |
| EP3006465A4 (en) | Anti-vegf antibody, and pharmaceutical composition for preventing, diagnosing or treating cancer or angiogenesis-related diseases, containing same | |
| EP2971213A4 (en) | IMPROVED ALUMINUM MAGNESIUM LITHIUM ALLOYS AND METHOD FOR THE PRODUCTION THEREOF | |
| DK3079476T3 (da) | Syreopløselige kobber-ammonium-komplekser og kobber-zink-ammonium-komplekser, sammensætninger, præparat, metoder og anvendelse | |
| PH12016501422A1 (en) | Functionalised benzopyran compounds and use thereof | |
| IL251676A0 (en) | Antibodies that bind to ccr6 and their uses | |
| PL3679069T3 (pl) | Przeciwciała przydatne w diagnostyce nowotworów | |
| SG11201506358PA (en) | Anti-cdh3 humanized antibody, drug conjugate thereof, and use thereof | |
| MX2015010023A (es) | Anticuerpos anti-cd83 y su uso. | |
| JP2015127308A5 (enExample) | ||
| CL2014002788A1 (es) | Combinación de anticuerpos anti-mif y los quimioterapeuticos gemcitabina, cisplatina y/o doxorubicina; y su uso contra el cancer. |